Assembly Biosciences Inc

ASMB
12,18
-0,72 (-5,58%)
Ultimo aggiornamento: 19:57:47
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/3/202421:05GLOBEAssembly Biosciences Reports Fourth Quarter and Year End..
08/2/202414:00GLOBEAssembly Biosciences Announces Effective Date of Reverse..
02/2/202422:05EDGAR2Form 8-K - Current report
19/1/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEAssembly Biosciences Provides Anticipated Development..
21/12/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
11/12/202322:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/12/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:05EDGAR2Form 8-K - Current report
22/11/202322:12EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202322:05GLOBEAssembly Biosciences Reports Inducement Grant Under Nasdaq..
10/11/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Viral..
08/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEAssembly Biosciences Reports Third Quarter 2023 Financial..
08/11/202314:00GLOBEAssembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief..
03/11/202321:05EDGAR2Form SC 13D/A - General statement of acquisition of..
31/10/202321:19EDGAR2Form SC 13D - General statement of acquisition of beneficial..
31/10/202317:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/10/202314:44DJNAssembly Biosciences Shares Soar Premarket on Gilead Pact
17/10/202313:51DJNGilead Taking Stake in Assembly Bio Under Antiviral..
17/10/202313:10EDGAR2Form 8-K - Current report
17/10/202313:00BWGilead and Assembly Biosciences Establish Partnership to..
11/10/202314:00GLOBEAssembly Biosciences to Present New Data at AASLD The Liver..
04/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:20EDGAR2Form 144 - Report of proposed sale of securities
04/10/202301:18EDGAR2Form 144 - Report of proposed sale of securities
02/10/202314:00GLOBEAssembly Biosciences Nominates Development Candidate..
19/9/202322:05GLOBEAssembly Biosciences to Highlight Pipeline Progress in HBV..
19/9/202300:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202322:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:12EDGAR2Form 8-K - Current report
09/8/202322:05GLOBEAssembly Biosciences Reports Second Quarter 2023 Financial..
07/8/202322:05EDGAR2Form 8-K - Current report
03/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202300:04EDGAR2Form 144 - Report of proposed sale of securities
03/8/202300:01EDGAR2Form 144 - Report of proposed sale of securities
25/7/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Herpes..
21/6/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Entry..
07/6/202314:00GLOBEAssembly Biosciences to Present Data at Upcoming..
23/5/202322:05GLOBEAssembly Biosciences to Present During the 2023 Jefferies..
04/5/202322:05GLOBEAssembly Biosciences Reports First Quarter 2023 Financial..
Apertura: 12,69 Min: 12,18 Max: 12,8847
Chiusura: 12,90

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network